Company Comparison
Carmat vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Carmat | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Vélizy-Villacoublay, France | San Diego |
| Founded | 2008 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series A |
| Total Funding | €63M | $48M |
| Valuation | — | — |
What They Build
Carmat
Carmat develops artificial heart devices designed to replace the function of a failing heart in patients with end-stage heart failure.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Carmat
AI Therapeutics
No investors listed.
Sector Overlap
Both Carmat and AI Therapeutics operate in Biotech.
Browse all Biotech companies →